PortfoliosLab logoPortfoliosLab logo
AIRO vs. INMB
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

AIRO vs. INMB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AIRO Group Holdings, Inc (AIRO) and INmune Bio, Inc. (INMB). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

AIRO vs. INMB - Yearly Performance Comparison


2026 (YTD)2025
AIRO
AIRO Group Holdings, Inc
-7.03%-65.92%
INMB
INmune Bio, Inc.
-27.56%-79.74%

Fundamentals

EPS

AIRO:

-$287.02

INMB:

-$2.00

PS Ratio

AIRO:

0.03

INMB:

563.69

Total Revenue (TTM)

AIRO:

$6.36B

INMB:

$50.00K

Gross Profit (TTM)

AIRO:

$2.84B

INMB:

$22.00K

EBITDA (TTM)

AIRO:

-$5.36B

INMB:

-$33.62M

Returns By Period

In the year-to-date period, AIRO achieves a -7.03% return, which is significantly higher than INMB's -27.56% return.


AIRO

1D
-11.26%
1M
-22.40%
YTD
-7.03%
6M
-60.39%
1Y
3Y*
5Y*
10Y*

INMB

1D
-0.88%
1M
-12.40%
YTD
-27.56%
6M
-45.41%
1Y
-85.53%
3Y*
-44.07%
5Y*
-37.99%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


AIRO Group Holdings, Inc

INmune Bio, Inc.

Return for Risk

AIRO vs. INMB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AIRO

INMB
INMB Risk / Return Rank: 77
Overall Rank
INMB Sharpe Ratio Rank: 77
Sharpe Ratio Rank
INMB Sortino Ratio Rank: 44
Sortino Ratio Rank
INMB Omega Ratio Rank: 44
Omega Ratio Rank
INMB Calmar Ratio Rank: 33
Calmar Ratio Rank
INMB Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AIRO vs. INMB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AIRO Group Holdings, Inc (AIRO) and INmune Bio, Inc. (INMB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

AIRO vs. INMB - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


AIROINMBDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.86

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.44

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.76

-0.26

-0.50

Correlation

The correlation between AIRO and INMB is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

AIRO vs. INMB - Dividend Comparison

Neither AIRO nor INMB has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AIRO vs. INMB - Drawdown Comparison

The maximum AIRO drawdown since its inception was -76.10%, smaller than the maximum INMB drawdown of -95.98%. Use the drawdown chart below to compare losses from any high point for AIRO and INMB.


Loading graphics...

Drawdown Indicators


AIROINMBDifference

Max Drawdown

Largest peak-to-trough decline

-76.10%

-95.98%

+19.88%

Max Drawdown (1Y)

Largest decline over 1 year

-86.41%

Max Drawdown (5Y)

Largest decline over 5 years

-95.98%

Current Drawdown

Current decline from peak

-75.47%

-95.94%

+20.47%

Average Drawdown

Average peak-to-trough decline

-49.47%

-59.63%

+10.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

67.80%

Volatility

AIRO vs. INMB - Volatility Comparison


Loading graphics...

Volatility by Period


AIROINMBDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.58%

Volatility (6M)

Calculated over the trailing 6-month period

48.63%

Volatility (1Y)

Calculated over the trailing 1-year period

101.52%

100.11%

+1.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

101.52%

87.48%

+14.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

101.52%

93.16%

+8.36%

Financials

AIRO vs. INMB - Financials Comparison

This section allows you to compare key financial metrics between AIRO Group Holdings, Inc and INmune Bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJuly
6.28B
0
(AIRO) Total Revenue
(INMB) Total Revenue
Values in USD except per share items